CMS Proposes Expansion of WCMSA Re-Review Process – The Good, The Bad & The Ugly

On February 11, 2014, the Centers for Medicare and Medicaid (CMS) announced its proposed changes to the current Medicare Set-Aside Arrangement re-review process, seeking comments and feedback by March 31, 2014. The current CMS process for WCMSA re-review requests is limited to situations where CMS is notified that the submitter omitted documentation from the original […]...Read more

Zohydro – Promised Relief or One More Opioid in the Spiral of Addiction?

When Zogenix announced on October 25, 2013 that the U.S. Food and Drug Administration (FDA) had approved ZohydroTM ER (hydrocodone bitartrate) extended-release capsules,  an extended-release oral formulation of hydrocodone without acetaminophen, the announcement came with the promise of continuous relief in the management of pain “severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment […]...Read more